{
    "Allocation": "Non-Randomized",
    "CompleteTime": 36,
    "DesignModel": "Sequential Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "yl201:  once every 3 weeks , ",
                "ArmGroupLabel": "Dose escalation",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "yl201",
                        "Duration": "once every 3 weeks",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: YL201"
                    ]
                }
            },
            {
                "ArmGroupDescription": "yl201:  once every 3 weeks , ",
                "ArmGroupLabel": "Dose expansion",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "yl201",
                        "Duration": "once every 3 weeks",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: YL201"
                    ]
                }
            }
        ]
    },
    "Enrollment": "196",
    "InterventionName": "",
    "Masking": "None (Open Label)",
    "NCTID": "NCT05434234",
    "Objective": "A Study of YL201 in Patients With Advanced Solid Tumors",
    "OfficialTitle": "A Phase 1, Multicenter, Nonrandomized, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL201 in Patients With Advanced Solid Tumors",
    "PopulationBox": {
        "Condition": "Advanced Solid Tumor",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "",
        "MinAge": "18 Years",
        "Participant": "196"
    },
    "PopulationRatio": "",
    "Title": "A Study of YL201 in Patients With Advanced Solid Tumors",
    "WashoutPeriod": ""
}